The Food and Drug Administration (FDA) issued new guidelines to introduce gene therapy treatments earlier than expected, but also wants to crack down on rogue clinics offering dangerous or unproven versions of those treatments.
"This is an incredibly significant development for the gene therapy, regenerative medicine sector," said Partner Michael J. Werner. "This should really open the door to a lot more gene therapies coming on the market quickly," said Mr. Warner.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.